Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.16NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
LN.1.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.25.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.16.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.57.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.44.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.2.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
BA.2.86.5NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.3.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.13NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
LM.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.17NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.15NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.1.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.63.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.27NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
KR.1.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
MD.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.64.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
KR.5NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
KZ.1.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
KS.1.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.47NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.23NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
KP.4.2.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
LK.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
LY.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.18NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
ML.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.11.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.17NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
BA.2.86.7NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
XBB.1.5.100NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-19644.4Hong Kong
XBB.1.19.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-19644.4Hong Kong
AH.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-19644.4Hong Kong
B.1.415.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-19644.4Hong Kong
S.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-19644.4Hong Kong
B.1.631NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-19644.4Hong Kong
B.1.1.218NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-19644.4Hong Kong
AY.82 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-19644.4Hong Kong
HK.3.4NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-19644.4Hong Kong
XBB.1.5.42NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-19644.4Hong Kong
B.1.377NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-19639.5China
B.1.448NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19636.2Germany
B.1.369NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19636.2Germany
B.1.564.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19636.2Germany
B.1.607NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19636.2Germany
B.1.571NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19636.2Germany
B.1.564NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19636.2Germany
HK.25ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-19628.8Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used